147 related articles for article (PubMed ID: 38409829)
21. Pediatric Sertoli-Leydig Cell Tumors of the Ovary: An Integrated Study of Clinicopathological Features, Pan-cancer-Targeted Next-generation Sequencing and Chromosomal Microarray Analysis From a Single Institution.
Yang B; Chour W; Salazar CG; Zamiara P; Schmidt RJ; Raca G; Shillingford N; Zhou S; Warren M; Parham DM; Pawel B; Wang LL
Am J Surg Pathol; 2024 Feb; 48(2):194-203. PubMed ID: 37946548
[TBL] [Abstract][Full Text] [Related]
22. DICER1 hotspot mutations in non-epithelial gonadal tumours.
Witkowski L; Mattina J; Schönberger S; Murray MJ; Choong CS; Huntsman DG; Reis-Filho JS; McCluggage WG; Nicholson JC; Coleman N; Calaminus G; Schneider DT; Arseneau J; Stewart CJ; Foulkes WD
Br J Cancer; 2013 Nov; 109(10):2744-50. PubMed ID: 24136150
[TBL] [Abstract][Full Text] [Related]
23. Somatic tumour testing establishes that bilateral DICER1-associated ovarian Sertoli-Leydig cell tumours represent independent primary neoplasms.
McCluggage WG; Chong AL; de Kock L; Foulkes WD
Histopathology; 2020 Aug; 77(2):223-230. PubMed ID: 32333409
[TBL] [Abstract][Full Text] [Related]
24. Testicular Neoplasms With Sex Cord and Stromal Components Harbor a Recurrent Pattern of Chromosomal Gains.
Acosta AM; Sholl LM; Maclean F; Kao CS; Ulbright TM
Mod Pathol; 2024 Jan; 37(1):100368. PubMed ID: 37871653
[TBL] [Abstract][Full Text] [Related]
25. Genetics and genomics of ovarian sex cord-stromal tumors.
Fuller PJ; Leung D; Chu S
Clin Genet; 2017 Feb; 91(2):285-291. PubMed ID: 27813081
[TBL] [Abstract][Full Text] [Related]
26. Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations.
Croce S; de Kock L; Boshari T; Hostein I; Velasco V; Foulkes WD; McCluggage WG
Int J Gynecol Pathol; 2016 Jul; 35(4):301-8. PubMed ID: 26598979
[TBL] [Abstract][Full Text] [Related]
27. Sertoli-Leydig cell tumor: a clinicopathological analysis in a comprehensive, national cohort.
Bekker P; Miland-Samuelsen AR; Smerdel MP; Schnack TH; Lauszus FF; Karstensen SH
Int J Gynecol Cancer; 2023 Dec; 33(12):1921-1927. PubMed ID: 37907261
[TBL] [Abstract][Full Text] [Related]
28. Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry.
Schultz KA; Pacheco MC; Yang J; Williams GM; Messinger Y; Hill DA; Dehner LP; Priest JR
Gynecol Oncol; 2011 Aug; 122(2):246-50. PubMed ID: 21501861
[TBL] [Abstract][Full Text] [Related]
29. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors.
Rio Frio T; Bahubeshi A; Kanellopoulou C; Hamel N; Niedziela M; Sabbaghian N; Pouchet C; Gilbert L; O'Brien PK; Serfas K; Broderick P; Houlston RS; Lesueur F; Bonora E; Muljo S; Schimke RN; Bouron-Dal Soglio D; Arseneau J; Schultz KA; Priest JR; Nguyen VH; Harach HR; Livingston DM; Foulkes WD; Tischkowitz M
JAMA; 2011 Jan; 305(1):68-77. PubMed ID: 21205968
[TBL] [Abstract][Full Text] [Related]
30. Ovarian sex cord-stromal tumors in patients with probable or confirmed germline DICER1 mutations.
Oost EE; Charles A; Choong CS; Leung YC; Salfinger S; Sonnendecker H; Tan J; Townshend S; Witkowski L; Foulkes WD; Stewart CJ
Int J Gynecol Pathol; 2015 May; 34(3):266-74. PubMed ID: 25844550
[TBL] [Abstract][Full Text] [Related]
31. Update on Ovarian Sex Cord-Stromal Tumors.
Ordulu Z
Clin Lab Med; 2023 Jun; 43(2):245-274. PubMed ID: 37169445
[TBL] [Abstract][Full Text] [Related]
32. Update on Ovarian Sex Cord-Stromal Tumors.
Ordulu Z
Surg Pathol Clin; 2022 Jun; 15(2):235-258. PubMed ID: 35715160
[TBL] [Abstract][Full Text] [Related]
33. Bilateral Ovarian Sertoli-Leydig Cell Tumors Harboring
Hughes CE; Liang J; Paulson V; Wang H
Fetal Pediatr Pathol; 2023 Jun; 42(3):472-478. PubMed ID: 36121434
[No Abstract] [Full Text] [Related]
34. [Sex cord-stromal tumors of the ovary : Current aspects with a focus on granulosa cell tumors, Sertoli-Leydig cell tumors, and gynandroblastomas].
Kommoss F; Lehr HA
Pathologe; 2019 Feb; 40(1):61-72. PubMed ID: 30659330
[TBL] [Abstract][Full Text] [Related]
35. DICER1 hot-spot mutations in ovarian gynandroblastoma.
Wang Y; Karnezis AN; Magrill J; Tessier-Cloutier B; Lum A; Senz J; Gilks CB; McCluggage WG; Huntsman DG; Kommoss F
Histopathology; 2018 Aug; 73(2):306-313. PubMed ID: 29660837
[TBL] [Abstract][Full Text] [Related]
36. DICER1 Mutation in Recurrent Ovarian Sertoli-Leydig Cell Tumor: A Case Report.
Liu S; Pokoradi AJ; Soboleski D; Childs T; Agrawal A
J Pediatr Adolesc Gynecol; 2023 Apr; 36(2):107-111. PubMed ID: 36402443
[TBL] [Abstract][Full Text] [Related]
37. [Application of molecular analysis in differential diagnosis of ovarian adult granulosa cell tumors].
Zheng XZ; Ma JH; Chen TB; Xu F; Zou ZY; Zhang LH; Jin YL; Zhan Y
Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):794-799. PubMed ID: 32746545
[No Abstract] [Full Text] [Related]
38. Practical roles for molecular diagnostic testing in ovarian adult granulosa cell tumour, Sertoli-Leydig cell tumour, microcystic stromal tumour and their mimics.
Rabban JT; Karnezis AN; Devine WP
Histopathology; 2020 Jan; 76(1):11-24. PubMed ID: 31846522
[TBL] [Abstract][Full Text] [Related]
39. Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of
Golmard L; Vasta LM; Duflos V; Corsini C; Dubois d'Enghien C; McMaster ML; Harney LA; Carr AG; Ling A; Dijoud F; Gauthier A; Miettinen M; Cost NG; Gauthier-Villars M; Orbach D; Irtan S; Haouy S; Schultz KA; Stoppa-Lyonnet D; Coupier I; Stewart DR; Sirvent N
J Med Genet; 2022 Apr; 59(4):346-350. PubMed ID: 33782093
[No Abstract] [Full Text] [Related]
40. Moderately differentiated Sertoli-Leydig cell tumour: a hormone-secreting neoplasm associated with DICER1 syndrome.
Khan S; Hodgson A
Int J Gynecol Cancer; 2023 Dec; 33(12):1981-1982. PubMed ID: 37543372
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
